The latest biotech news

News and Trends 29 Oct 2015

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

Cellectis is a leader in immuno-oncology CAR-T therapies from France, which might revolutionise cancer treatments. Now, the next step in the CAR-T campaign is to step away from personalised (autologous) therapies, which are time-consuming and expensive, to instead produce an allogenic version available to all. So, what is CAR-T? You can read a more in-depth […]

October 29, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 29 Oct 2015

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

ERRATUM: I published a first article on Celyad’s new patent on last Tuesday where I made an error of judgement. Celyad’s US patent covers allogeneic CAR-T modified to reduce immunogenicity. In my previous article, I wrote that Celyad stated having obtained the first US patent on CAR-T, which is wrong. Last Tuesday, Celyad announced having […]

October 29, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 29 Oct 2015

The NeoFood Project: A Basque Coastal Hunt for Algae which produce Essential Fatty Acids

The Neofood project from the Basque Country (Spain) is searching for novel Oceanic strains of algae in salt-marshes around the coast, specifically those that naturally produce essential fatty acids. These algae will serve as an alternative to fish oils for Omega-3 food supplements. A syndicate of Agricultural focused researchers are on the hunt for more […]

October 29, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

We still haven’t fully sequenced the domestic wheat genome! Now the US Dragen chip has the answer for speedy whole-genome analysis, which The Genome Analysis Centre (TGAC) in England will test out for UK food-security research. Dragen is a Bio-IT platform processing chip which has clinical pipelines for many areas in research, including the Microbiome, […]

October 28, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

Horizon Discovery is a gene-editing tools specialist with various biotech partnerships over their cell-line catalogues. A UK expansion for Horizon is now underway, with the launch of a new genomics eCommerce webshop and the expansion of their headquarters. Horizon Discovery provides personalized translational medicine products and services, such as bespoke cell-lines for drug discovery and […]

October 28, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Bath, in South West England, has a lot more besides its historic beauty…The Jenkins Chemistry lab at the University of Bath has a fair few innovative solutions to the problem of infectious disease detection. Their latest design is a burns dressing which glows when a pathogenic biofilm is detected (as part of the Bacteriosafe Project) […]

October 28, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2015

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

The Belgian biomanufacturing company Univercells and the Japanese pharmaceutical company Takeda have signed a strategic partnership agreement. Univercells has closed a €3M equity investment with Takeda Ventures to produce affordable vaccines. Univercells provides single-use cost-efficient bioprocess solutions to lead the next generation in biomanufacturing. Under the terms of the agreement, the two biotechs will launch a […]

October 27, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2015

Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease

Karen Aiach had no background in science or the biotech industry, yet when her daughter Ornella was diagnosed with the super-rare Sanfilippo syndrome this inspired her to co-found and become the CEO of Lysogene, today a clinical-stage biotech based in Paris, France. Now Ornella is participating in the ongoing clinical trials for a new gene […]

October 27, 2015 - 7 minutesmins - By Dani Bancroft

News and Trends 26 Oct 2015

Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal

CRIPSR’s hype is not going down yet. CRIPSR/Cas9 or Cpf1 is a revolutionising gene editing tool, which almost won the Nobel Prize of this year (it won nearly all the other biology prizes already). It also caught great interest from the industry and venture capitalists. The leading Biotechs includes: Editas, Boston-based and clozed a $120M found […]

October 26, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Oct 2015

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

The fight against Alzheimer‘s with the World Health Organization and the G8 Dementia Summit rallies a collective of biotech industry specialists also wanting in on the battle front. The latest development in the Dementia Discovery Fund (DDF) includes US Biogen‘s dramatic cuts to redirect $250M into the Neurodegenerative disease venture, and investment into $100M ‘A’ […]

October 26, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 26 Oct 2015

The First Ever Oncolytic Immunotherapy is Set to Reach the European Market

Amgen is now months away from a European approval with Imlygic (also known as T-VEC) – the first oncolytic immunotherapy for advanced melanoma. The Committee for Medicinal Products for Human Use (CHMP) and the scientific committee of the European Medicines Agency (EMA), have reacted positively. Melanoma is a type of skin cancer that is characterized by the uncontrolled growth of melanocytes, […]

October 26, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 26 Oct 2015

Financial Storm approaching? EU Biotechs start postponing their IPOs in London …

Biotech financing beats record over record since beginning of 2014. Financing has never been as high in Europe (though of course, we know this has always been the case for the US). Just look at Neil Woodford, famous british investor who raised €1.1Bn for its fund and injected it in many companies like Immuncore (2nd biggest VC round […]

October 26, 2015 - 3 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

The NeoFood Project: A Basque Coastal Hunt for Algae which produce Essential Fatty Acids

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease

Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

The First Ever Oncolytic Immunotherapy is Set to Reach the European Market

Financial Storm approaching? EU Biotechs start postponing their IPOs in London …

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!